NRx Pharmaceuticals reports progress and outlook
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lotus Pharmaceutical Co Ltd (1795)
Lotus Pharmaceutical Co Ltd stock price live, this page displays TW 1795 stock exchange data. View the 1795 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Lotus Pharmaceutical Co Ltd real time stock price chart below.
What Is the Lotus Pharmaceutical Co Ltd Stock Price Today?
The Lotus Pharmaceutical Co Ltd stock price today is 260.50.
What Is the Stock Symbol for Lotus Pharmaceutical Co Ltd?
The stock symbol for Lotus Pharmaceutical Co Ltd is "1795."
What Stock Exchange Does Lotus Pharmaceutical Co Ltd Trade On?
Lotus Pharmaceutical Co Ltd is listed and trades on the Taiwan stock exchange.
Is Lotus Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Lotus Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1795 quote. (ISIN: TW0001795003)
What Is the Lotus Pharmaceutical Co Ltd Stock Price Today?
The Lotus Pharmaceutical Co Ltd stock price today is 260.50.
What Is the Stock Symbol for Lotus Pharmaceutical Co Ltd?
The stock symbol for Lotus Pharmaceutical Co Ltd is "1795."
What Stock Exchange Does Lotus Pharmaceutical Co Ltd Trade On?
Lotus Pharmaceutical Co Ltd is listed and trades on the Taiwan stock exchange.
Is Lotus Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Lotus Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1795 quote. (ISIN: TW0001795003)
Taiwan
Currency in TWD
260.50
-2.00(-0.76%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
260.00
264.50
52 wk Range
210.50
347.00
1795 Scorecard
Full Analysis
Has raised its dividend for 4 consecutive years
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
260.00264.50
52 wk Range
210.50347.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.78%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.78%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1795 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
394.60
Upside
+51.48%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
Lotus Pharma Company Profile
Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system diseases. The company also provides over-the-counter products. In addition, it engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. Further, the company offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. The company has strategic partnership with NRX Pharmaceuticals. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.
Compare 1795 to Peers and Sector
Metrics to compare | 1795 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1795PeersSector | |
|---|---|---|---|---|
P/E Ratio | 16.0x | 16.7x | −0.6x | |
PEG Ratio | 1.40 | 0.15 | 0.00 | |
Price/Book | 3.4x | 3.6x | 2.6x | |
Price / LTM Sales | 3.9x | 3.9x | 3.1x | |
Upside (Analyst Target) | 30.1% | 10.3% | 53.0% | |
Fair Value Upside | Unlock | 17.0% | 8.0% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 394.60
(+51.48% Upside)
Earnings
Latest Release
Nov 07, 2024
EPS / Forecast
5.98 / 5.96
Revenue / Forecast
5.23B / 5.23B
FAQ
What Is the Lotus Pharma (1795) Stock Price Today?
The Lotus Pharma stock price today is 260.50.
What Stock Exchange Does Lotus Pharma Trade On?
Lotus Pharma is listed and trades on the Taiwan stock exchange.
What Is the Stock Symbol for Lotus Pharma?
The stock symbol for Lotus Pharma is "1795."
Does Lotus Pharma Pay Dividends? What’s The Current Dividend Yield?
The Lotus Pharma dividend yield is 1.78%.
What Is the Lotus Pharma Market Cap?
As of today, Lotus Pharma market cap is 69.14B.
What is Lotus Pharma Earnings Per Share?
The Lotus Pharma EPS is 16.56.
What Is the Next Lotus Pharma Earnings Date?
Lotus Pharma will release its next earnings report on 12 Mar 2025.
From a Technical Analysis Perspective, Is 1795 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.